|
Sign In to gain access to subscriptions and/or personal tools.
|
Review 2005 Research Workshop |
Hyperglycemia During Critical Illness
Stanley A. Nasraway, Jr, MD, FCCM
From the Department of Surgery, the Tufts–New England Medical
Center, and the Tufts University School of Medicine, Boston,
Massachusetts
Correspondence: Stanley A. Nasraway, Jr, MD, FCCM, Department of Surgery,
Tufts–New England Medical Center, Washington St, Box 4630, Boston, MA
02111. Electronic mail may be sent to
Snasraway{at}tufts-nemc.org.
Background: We sought to review the literature describing the
benefits of tight glycemic control in critically ill patients, comparing
outcome differences in subgroup populations. Methods: We searched
PubMed for relevant literature on the topic of hyperglycemia and its
management in the intensive care unit. Results: Overwhelming evidence
in both surgical and medical patients conclusively demonstrates that
hyperglycemia is a marker of severity of illness and is also an independent
determinant of bad outcome, largely from infectious complications. Randomized
trial evidence, in conjunction with historically controlled trials, supports
the use of intensive insulin therapy and euglycemic control in critically ill
patients, with nondiabetics possibly benefiting even more than diabetic
patients. Euglycemia is best achieved, and hypoglycemia attenuated, through
use of a protocolized approach. Further elaboration as to what threshold range
defines euglycemia in patient subpopulations is needed and what pitfalls must
be avoided in this practice. Development of continuous blood glucose
monitoring has started and will someday be incorporated into routine practice
in the same way that continuous electrocardiographic monitoring and pulse
oximetry are standards of care in the intensive care unit.
Conclusions: Hyperglycemia is a predictor of death and complications
in critically ill patients. Early aggregated study results show that control
of hyperglycemia improves outcomes. Well-designed studies involving thousands
of patients have started to better elucidate the concomitant promoters of
hyperglycemia and to better quantify the benefits from tight glycemic
control.
Journal of Parenteral and Enteral Nutrition, Vol. 30, No. 3,
254-258 (2006)
DOI: 10.1177/0148607106030003254

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. W. Dunser and W. R. Hasibeder
Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress
J Intensive Care Med,
September 1, 2009;
24(5):
293 - 316.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Thompson and J. Duffy
Nutrition Support Challenges in Hematopoietic Stem Cell Transplant Patients
Nutr Clin Pract,
October 1, 2008;
23(5):
533 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. H. Stucky, M. Moncure, M. Hise, C. M. Gossage, and D. Northrop
How Accurate Are Resting Energy Expenditure Prediction Equations in Obese Trauma and Burn Patients?
JPEN J Parenter Enteral Nutr,
July 1, 2008;
32(4):
420 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ellger, M. C. Richir, P. A. M. van Leeuwen, Y. Debaveye, L. Langouche, I. Vanhorebeek, T. Teerlink, and G. Van den Berghe
Glycemic Control Modulates Arginine and Asymmetrical-Dimethylarginine Levels during Critical Illness by Preserving Dimethylarginine-Dimethylaminohydrolase Activity
Endocrinology,
June 1, 2008;
149(6):
3148 - 3157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Goran
The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction
Eur. Heart J.,
August 2, 2007;
28(16):
2042 - 2042.
[Full Text]
[PDF]
|
 |
|
|
|